Security
Prenetics Global Limited Warrant · PRENW
PRENWNASDAQWarrantCurrentCIK 1876431Updated Oct 14, 2026
PRENW price & chart
Loading TradingView…
NASDAQ:PRENW on TradingView ↗About the company
Prenetics (NASDAQ: PRE) is a leading health sciences company dedicated to advancing human health and longevity. The Company’s flagship consumer brand, IM8, co-founded with David Beckham and championed by World No. 1 tennis player Aryna Sabalenka, is redefining the premium daily nutrition category through science-backed formulations and global brand partnerships. Since its launch, IM8 has become one of the fastest-growing brands in consumer health, achieving an impressive milestone of surpassing $100 million in annualized recurring revenue within just 11 months of operations, and is now sold in more than 40 countries worldwide.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2024 · USDSource
Source
Source
cash flow · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Profit or LossUSD | -49,806,000Source | -64,777,332Source | -190,453,387Source | -174,016,842Source |
| Additional Financial Items | ||||
| AdjustmentsForDecreaseIncreaseInTradeAccountReceivableUSD | -563,000Source | 37,633,287Source | 6,966,189Source | -24,050,811Source |
| AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociatesUSD | 1,244,000Source | -858,900Source | — | — |
| AdjustmentsForIncomeTaxExpenseUSD | -7,874,000Source | -385,841Source | — | — |
| AdjustmentsForIncreaseDecreaseInTradeAccountPayableUSD | -4,682,000Source | -5,617,891Source | -2,627,637Source | -3,457,215Source |
| AdjustmentsForSharebasedPaymentsUSD | 7,846,000Source | 10,588,944Source | 31,580,383Source | 22,494,918Source |
| AdjustmentsForUnrealisedForeignExchangeLossesGainsUSD | 119,000Source | 819,653Source | 223,927Source | -285,025Source |
| GoodwillUSD | 37,364,000Source | 29,170,123Source | 33,800,276Source | 3,978,065Source |
| InterestPaidClassifiedAsFinancingActivitiesUSD | 0Source | 0Source | 172,978Source | 33Source |
| InterestPaidClassifiedAsOperatingActivitiesUSD | — | — | 59,504Source | -20,284Source |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesUSD | 2,766,000Source | 3,476,380Source | 2,121,981Source | 1,504,946Source |
| ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivitiesUSD | 42,000Source | 99,348Source | 49,938Source | 713,523Source |
| PurchaseOfIntangibleAssetsClassifiedAsInvestingActivitiesUSD | 59,000Source | 566,523Source | 1,394,553Source | 2,865,315Source |
income statement · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cost of Goods and Services Sold | —Source | —Source | —Source | —Source |
| Total RevenueUSD | — | 21,742,675Source | 275,761,298Source | 275,852,753Source |
| Additional Financial Items | ||||
| BasicEarningsLossPerShareUSD per share | -3.71Source | -5.58Source | -2.5Source | -11.92Source |
| DeferredTaxExpenseIncomeRecognisedInProfitOrLossUSD | -466,000Source | -315,796Source | -279,633Source | 2,530,047Source |
| DepreciationRightofuseAssetsUSD | 2,052,000Source | 1,761,394Source | 2,087,167Source | 1,542,566Source |
| DilutedEarningsLossPerShareUSD per share | -3.71Source | -5.58Source | -2.5Source | -11.92Source |
| EmployeeBenefitsExpenseUSD | 35,056,000Source | 38,959,670Source | 141,845,247Source | 99,326,544Source |
| ExpenseFromSharebasedPaymentTransactionsWithEmployeesUSD | 7,361,000Source | 10,495,706Source | 31,339,185Source | 22,141,614Source |
| FinanceCostsUSD | — | — | 4,198,184Source | 5,238,030Source |
| GainsLossesRecognisedWhenControlInSubsidiaryIsLostUSD | — | 0Source | — | -292,132Source |
| GrossProfitUSD | 15,400,000Source | 8,829,887Source | 131,554,886Source | 106,131,211Source |
| ImpairmentLossRecognisedInProfitOrLossGoodwillUSD | 0Source | 3,900,268Source | -3,272,253Source | — |
| ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossUSD | 0Source | 3,900,268Source | — | — |
| IncomeTaxExpenseContinuingOperationsUSD | -7,874,000Source | -269,359Source | 7,147,104Source | 3,732,744Source |
| InterestExpenseOnLeaseLiabilitiesUSD | 203,000Source | 241,497Source | 244,085Source | 205,915Source |
| NetForeignExchangeLossUSD | — | — | 688,725Source | — |
| OtherFinanceCostUSD | 203,000Source | 119,662Source | 4,198,184Source | 5,238,030Source |
| OtherOperatingIncomeExpenseUSD | 2,745,000Source | 4,507,103Source | 404,643Source | 138,948Source |
| PostemploymentBenefitExpenseDefinedContributionPlansUSD | 700,000Source | 718,933Source | 861,863Source | 562,427Source |
| ProfitLossAttributableToNoncontrollingInterestsUSD | -3,502,000Source | -2,053,461Source | -54Source | -7,569Source |
| ProfitLossAttributableToOwnersOfParentUSD | -46,304,000Source | -62,723,871Source | -190,453,333Source | -174,009,273Source |
| ProfitLossBeforeTaxUSD | -57,702,000Source | -56,669,031Source | -183,306,283Source | -170,284,098Source |
| ProfitLossFromOperatingActivitiesUSD | -48,144,000Source | -51,906,718Source | -23,303,188Source | -10,217,528Source |
| ResearchAndDevelopmentExpenseUSD | 10,923,000Source | 11,661,760Source | 15,519,228Source | 10,563,952Source |
| RevenueFromInterestUSD | 2,039,000Source | 3,923,279Source | 472,189Source | 3,980Source |
| ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodUSD | -1,779,000Source | -858,900Source | — | — |
Offerings
Registration 333-294765
Filing attachments
ex991-2026q1.htm · 6-K · 2026-06-10
Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue Q1 2026 revenue of $36.0 million with IM8 revenue of $33.8 million, up 23.1% from IM8 revenue of $27.4 million in Q4 2025 and nearly 6x year-over-year from IM8 revenue of $5.7 million in Q1 2025 Raises full-year 2026 IM8 revenue guidance to $190 million to $210 million (previously $180 million to $200 million) Projects Q2 2026 revenue of $…
Read attachment ↗ex991-press_releasexhudson.htm · 6-K · 2026-06-04
Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion Hudson Leogrande is the Founder and CEO of Comfrt - a multi-billion-dollar DTC brand projected to exceed $1 billion in revenue in 2026 Comfrt is one of the largest advertisers on both TikTok and Meta; Comfrt’s 600,000-strong TikTok affiliate community drives organic cultural reach that unlocks Meta paid acquisition Mr. Leogrande join…
Read attachment ↗ex991-2026q1prelim.htm · 6-K · 2026-05-14
Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M - $210M Prenetics records Q1 2026 revenue of $36.0 million with IM8 revenue of $33.8 million, up 23.1% from IM8 revenue of $27.4 million in Q4 2025 Raises full-year 2026 IM8 revenue guidance to $190 million to $210 million (previously $180 million to $200 million) Company projects Q2 2026 revenue of $46 million to $48 million, with IM8 cont…
Read attachment ↗ex427actgenomicsspa.htm · 20-F · 2026-04-30
Exhibit 4.27 Certain information have been excluded from this exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential. Certain schedules have been excluded from this exhibit because they are both (i) not material and (ii) not otherwise disclosed in the exhibit or our annual report on Form 20-F for the fiscal year ended December 31, 2025. The excluded information is indicated by brackets containing asterisks ("[***]"). The registrant wi…
Read attachment ↗ex428europaapa.htm · 20-F · 2026-04-30
Exhibit 4.28 Certain information have been excluded from this exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential. Certain schedules have been excluded from this exhibit because they are both (i) not material and (ii) not otherwise disclosed in the exhibit or our annual report on Form 20-F for the fiscal year ended December 31, 2025. The excluded information is indicated by brackets containing asterisks ("[***]"). The registrant wi…
Read attachment ↗ex429insignia2spa.htm · 20-F · 2026-04-30
Exhibit 4.29 Certain information have been excluded from this exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential. Certain schedules have been excluded from this exhibit because they are both (i) not material and (ii) not otherwise disclosed in the exhibit or our annual report on Form 20-F for the fiscal year ended December 31, 2025. The excluded information is indicated by brackets containing asterisks ("[***]"). The registrant wi…
Read attachment ↗